From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
 | Sensitivity | Specificity | Accuracy | AUC |
---|---|---|---|---|
New CAPS criteria (clinical + genetics) | 0.72 | 1 | 0.96 | 0.86 |
Kuemmerle CAPS criteria | 0.88 | 0.82 | 0.83 | 0.85 |
New FMF criteria (clinical + genetics) | 0.89 | 1 | 0.96 | 0.94 |
Livneh criteria | 0,9 | 0,58 | 0,7 | 0,74 |
Tel Hashomer | 0,59 | 0,95 | 0,64 | 0,77 |
Pediatric FMF criteria | 0,61 | 0,94 | 0,83 | 0,77 |
New MKD criteria (clinical + genetics) | 0.74 | 1 | 0.98 | 0.87 |
Clinical guideline | 0.77 | 0.53 | 0.56 | 0.65 |
New TRAPS criteria (clinical + genetics) | 0.74 | 1 | 0.97 | 0.87 |
New PFAPA clinical criteria | 0.66 | 0.97 | 0.9 | 0.82 |
Modified Marshall criteria | 0.46 | 0.91 | 0.81 | 0.69 |